Supplementation of Lycium barbarum Polysaccharide Combined with Aerobic Exercise Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis via AMPK/PPARα/PGC-1α Pathway

Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease

(2022) Tobias Puengel et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Effect of Aerobic Exercise Intensity on Energy Expenditure and Weight Loss in Severe Obesity—A Randomized Controlled Trial

(2021) Jarle Berge et al.   Obesity

Management of non-alcoholic fatty liver disease

(2021) Maria Letizia Petroni et al.   BMJ-British Medical Journal

Cordycepin Ameliorates Nonalcoholic Steatohepatitis via Activation of AMP‐Activated Protein Kinase Signaling Pathway

(2021) Tian Lan et al.   HEPATOLOGY

Therapeutic pipeline in nonalcoholic steatohepatitis

(2021) Raj Vuppalanchi et al.   Nature Reviews Gastroenterology & Hepatology

Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Double‐Blind Phase 2 Trial

(2021) Samer Gawrieh et al.   HEPATOLOGY

Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation

(2021) Lu-Lu Gao et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Non-alcoholic fatty liver disease

(2021) Elizabeth E Powell et al.   LANCET

Evidence-Based Aerobic Exercise Training in Metabolic-Associated Fatty Liver Disease: Systematic Review with Meta-Analysis

(2021) Joanna Słomko et al.   Journal of Clinical Medicine

A homogeneous polysaccharide from Lycium barbarum: Structural characterizations, anti-obesity effects and impacts on gut microbiota

(2021) Yu Yang et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Lycium barbarum polysaccharide protects ARPE‑19 cells against H2O2‑induced oxidative stress via the Nrf2/HO‑1 pathway

(2021) Ran Liang et al.   Molecular Medicine Reports

Aerobic Exercise Training Prevents Insulin Resistance and Hepatic Lipid Accumulation in LDL Receptor Knockout Mice Chronically Fed a Low-Sodium Diet

(2021) Guilherme da Silva Ferreira et al.   Nutrients

Therapeutic Targeting of Nonalcoholic Fatty Liver Disease by Downregulating SREBP-1C Expression via AMPK-KLF10 Axis

(2021) Yu-Chi Chen et al.   Frontiers in Molecular Biosciences

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway

(2020) Charng-Cherng Chyau et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis

(2020) Chongshu Jian et al.   Cell Metabolism

Nonalcoholic Steatohepatitis

(2020) Adam C. Sheka et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease

(2020) Walid Kamal Abdelbasset et al.   MEDICINE

Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States

(2020) Zobair M. Younossi et al.   Clinical Gastroenterology and Hepatology

Effects of extraction methods on immunology activity and chemical profiles of Lycium barbarum polysaccharides

(2020) Wei Hao et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease

(2020) Divya P. Kumar et al.   Scientific Reports

TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation

(2020) Hee-Seon Park et al.   Autophagy

Inhibition of fatty acid synthase with FT‐4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non‐alcoholic fatty liver disease: Results from two early‐phase randomized trials

(2020) Carine Beysen et al.   DIABETES OBESITY & METABOLISM

Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-α signaling in obese mice

(2020) Tiego Aparecido Diniz et al.   LIFE SCIENCES

A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH)

(2019) Manca Povsic et al.   ADVANCES IN THERAPY

Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway

(2019) Xiaopeng Zhu et al.   FREE RADICAL BIOLOGY AND MEDICINE

Curcumin analog CUR5–8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity

(2019) Eun Soo Lee et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease

(2018) David Højland Ipsen et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis

(2018) Eric J. Lawitz et al.   Clinical Gastroenterology and Hepatology

Lycium barbarum polysaccharides: Extraction, purification, structural characterisation and evidence about hypoglycaemic and hypolipidaemic effects. A review

(2018) Alessandra Masci et al.   FOOD CHEMISTRY

Pioglitazone and bladder cancer risk: a systematic review and meta-analysis

(2018) Huilin Tang et al.   Cancer Medicine

Nuciferine ameliorates hepatic steatosis in high-fat diet/streptozocin-induced diabetic mice through PPARα/PGC1α pathway

(2018) Chao Zhang et al.   BRITISH JOURNAL OF PHARMACOLOGY

Burden of Illness and Economic Model for Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States

(2018) Zobair M. Younossi et al.   HEPATOLOGY

Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis

(2018) Zobair Younossi et al.   HEPATOLOGY

Lycium barbarum polysaccharides improve hepatic injury through NFkappa-B and NLRP3/6 pathways in a methionine choline deficient diet steatohepatitis mouse model

(2018) Jia Xiao et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis

(2018) Simona Leoni et al.   WORLD JOURNAL OF GASTROENTEROLOGY

PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation

(2018) Ching-Feng Cheng et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Multi-regulatory network of ROS: the interconnection of ROS, PGC-1 alpha, and AMPK-SIRT1 during exercise

(2017) Anand Thirupathi et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Effects of aerobic exercise on lipids and lipoproteins

(2017) Yating Wang et al.   Lipids in Health and Disease

AMPK as a Therapeutic Target for Treating Metabolic Diseases

(2017) Emily A. Day et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD

(2016) Alexandra Montagner et al.   GUT

Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice

(2016) Han-Sol Park et al.   Diabetes & Metabolism Journal

Lycium barbarum polysaccharide attenuates high-fat diet-induced hepatic steatosis by up-regulating SIRT1 expression and deacetylase activity

(2016) Li Jia et al.   Scientific Reports

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

(2015) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review

(2014) Bogna Grygiel-Górniak   Nutrition Journal

Dietary Lycium barbarum Polysaccharide Induces Nrf2/ARE Pathway and Ameliorates Insulin Resistance Induced by High-Fat via Activation of PI3K/AKT Signaling

(2014) Yi Yang et al.   Oxidative Medicine and Cellular Longevity

Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model

(2014) Jia Xiao et al.   Scientific Reports

Crude Extracts fromLycium barbarumSuppress SREBP-1c Expression and Prevent Diet-Induced Fatty Liver through AMPK Activation

(2014) Wang Li et al.   Biomed Research International

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

(2014) Hannele Yki-Järvinen   Lancet Diabetes & Endocrinology

Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease

(2013) Jennifer E. Lambert et al.   GASTROENTEROLOGY

Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease

(2012) Ilaria Croci et al.   GUT

PGC-1 coactivators in the control of energy metabolism

(2011) C. Liu et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice

(2011) Yu Li et al.   Cell Metabolism

AMPK and SIRT1: a long-standing partnership?

(2010) Neil B. Ruderman et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Comparative Analysis of Gene Regulation by the Transcription Factor PPARα between Mouse and Human

(2009) Maryam Rakhshandehroo et al.   PLoS One